Active Ingredient(s):Nanoparticle Albumin-Bound Paclitaxel FDA Approved: * January 7, 2005 Pharm Company: *ABRAXIS BIOSCIENCE Category:Cancer
Protein-bound paclitaxel, also known as nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and pancreatic cancer, among others. Paclitaxel kills cancer cells by preventing the normal breakdown of microtubules during cell division. In this formulation, paclitaxel is bonded to albumin as a delivery vehicle. It is manufacture...
* May have multiple approval dates, manufacturers, or labelers.
Abraxane 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Suspension